BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17389456)

  • 1. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
    Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
    Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
    Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G
    Thyroid; 2014 Nov; 24(11):1600-6. PubMed ID: 25110922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
    Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
    G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.
    Tanaka K; Sugitani I; Fujimoto Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1074-8. PubMed ID: 21791572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.
    Foote RL; Molina JR; Kasperbauer JL; Lloyd RV; McIver B; Morris JC; Grant CS; Thompson GB; Richards ML; Hay ID; Smallridge RC; Bible KC
    Thyroid; 2011 Jan; 21(1):25-30. PubMed ID: 21162687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic thyroid carcinoma: a therapeutic dilemma.
    Chang HS; Nam KH; Chung WY; Park CS
    Yonsei Med J; 2005 Dec; 46(6):759-64. PubMed ID: 16385650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.
    Sugitani I; Miyauchi A; Sugino K; Okamoto T; Yoshida A; Suzuki S
    World J Surg; 2012 Jun; 36(6):1247-54. PubMed ID: 22311136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Undifferentiated carcinoma of the thyroid].
    Amodeo C; Caglià P; Gandolfo L; Veroux M; Donati M; Immè A
    Tumori; 2003; 89(4 Suppl):205-6. PubMed ID: 12903594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
    Pacheco-Ojeda LA; Martínez AL; Alvarez M
    Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
    Heron DE; Karimpour S; Grigsby PW
    Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
    Batori M; Chatelou E; Straniero A; Ruggieri M
    Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.
    Segerhammar I; Larsson C; Nilsson IL; Bäckdahl M; Höög A; Wallin G; Foukakis T; Zedenius J
    J Surg Oncol; 2012 Dec; 106(8):981-6. PubMed ID: 22674491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for Korean patients with anaplastic thyroid carcinoma.
    Kim TY; Kim KW; Jung TS; Kim JM; Kim SW; Chung KW; Kim EY; Gong G; Oh YL; Cho SY; Yi KH; Kim WB; Park DJ; Chung JH; Cho BY; Shong YK
    Head Neck; 2007 Aug; 29(8):765-72. PubMed ID: 17274052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated therapeutic strategies for anaplastic thyroid carcinoma.
    Buzzoni R; Catena L; Cortinovis D; Dognini G; Bajetta E
    Tumori; 2003; 89(5):544-6. PubMed ID: 14870782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.